rawfin.tv
Trails Edge Capital Acquires 1.1 Million Shares of Syndax Pharmaceuticals
MarketsstocksAI Generated

Trails Edge Capital Acquires 1.1 Million Shares of Syndax Pharmaceuticals

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Trails Edge Capital Partners LP has established a new position by acquiring 1,110,000 shares in Syndax Pharmaceuticals, Inc. (SNDX). This investment indicates growing institutional interest in the biotechnology firm.

Institutional InvestmentPharmaceuticalsBiotechFund Management

Related Articles

S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

stocks
Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

stocks
Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

stocks
Barclays Workforce Trimmed 5% as Bank Increases Focus on AI

Barclays Workforce Trimmed 5% as Bank Increases Focus on AI

stocks